miRNA Sequencing and Assay Market - Trends Forecast Till 2028

Market Overview

The microRNA (miRNA) sequencing and assay market is expected to reach USD 468.99 million by 2027 from USD 192.31 million in 2019; it is estimated to grow at a CAGR of 11.9% from 2021 to 2028.

The advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing are some of the factors that have supported long-term expansion for miRNA Sequencing and Assay Market.

Key Findings

miRNA Sequencing and Assay Market is segmented into product, technology, end user and geography.

Product segment is segmented into library preparation and consumables.

Technology segment is segmented into sequencing by synthesis, nanopore and ion semiconductor sequencing.

End user segment is segmented into research institute, academia and CRO.

Geographically, miRNA Sequencing and Assay Market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Competitive Landscape

Key players in miRNA Sequencing and Assay Market are Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK)

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
• Gain authentic and granular data access for miRNA Sequencing and Assay market so as to understand the trends and the factors involved behind changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope